Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this exciting learning session on managing Ph negative Acute lymphoblastic leukemia in adults.
Acute Lymphoblastic Leukemia (ALL) is a cancer of the blood and bone marrow that progresses rapidly without treatment. It can reoccur after being in remission from previous treatment. It has been noted that refractory ALL did not respond to treatment indicating the previous treatments did not kill enough leukemia cells (blasts) to reach complete remission.
Ph-positive ALL is a special type of ALL in which a genetic mutation is observed in the Philadelphia chromosome. In the case of Ph-negative ALL, genetic disparities are also observed and most importantly in Ph neg ALL there is a disproportionate survival rate among the patients.
Managing Ph neg ALL often becomes difficult, however, the procedures of management of Philadelphia chromosome (Ph)–negative acute lymphoblastic leukemia (ALL) have changed dramatically in recent years leading to a positive vibe for the situation.
Therefore, have overall knowledge regarding the management of Ph negative ALL. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Q&A: Breast cancer facts that could save lives
2.
No Survival Bump in Metastatic NSCLC With Addition of ADC to Immunotherapy
3.
Anticoagulation for 12 months has been found to improve outcomes in cancer patients with minor blood clots.
4.
Woman Loses 6-Year Battle With Mouth Tumor
5.
EMA OKs Two Treatments for Small Cell Lung Cancer
1.
HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment
2.
Everything You Need to Know About Leiomyomas: A Comprehensive Guide
3.
Geriatric Medicine Through Long-Term Functional Survivorship After Cancer in Older Adults
4.
Optimizing Chemotherapy Dosing: From Phase 1 Dose Escalation to Modification
5.
Spatial Mapping of Tumor Cell States: Integrating Biology, Technology, and Clinical Practice
1.
International Conference on Cancer Nursing and Rehabilitation Strategies
2.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
3.
International Conference on Innovations in Critical Care for Oncology and Cardiology
4.
International Symposium on Oncology, Cardiology and Critical Care Innovations
5.
International Conference on Cancer Nursing and Hematology Support
1.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
2.
Understanding the Common Causes of Anemia
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
4.
Clinical Insights in Hematology
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation